Introduction
Human herpesvirus-6 (HHV-6) was first isolated in 1986 from the blood of six patients with lymphoproliferative disorders, two of whom also presented with AIDS (Salahuddin et al., 1986) . has been demonstrated to be the causative agent of the childhood disease exantheum subitum, infecting over 90 % of the population by the age of 2 years (Yamanishi et al., 1988) . This illness is characterized by a high-grade fever, often followed by the appearance of a rash, and in most cases the symptoms generally resolve within 3-6 days. However, neurological complications have been reported and primary HHV-6 infection is responsible for approximately one-third of febrile seizures observed in children (Hall et al., 1994) .
Like other herpesviruses, HHV-6 is maintained in a latent state after primary infection. Reactivation of HHV-6 poses a serious health problem for immunocompromised individuals, particularly patients undergoing bone marrow transplantations and victims of AIDS (Drobyski et al., 1993 ; Lusso & Gallo, 1995) . Here, the virus has been demonstrated to be an opportunistic pathogen and in some cases is responsible for causing fatal pneumonitis (Carrigan et al., 1991 ; Cone et al., 1993 ; Knox et al., 1995) . Autopsy reports of AIDS patients have documented widespread dissemination of HHV-6, detecting the virus in the lung, spleen, kidney, Author for correspondence : Carol Wu.
Fax j1 860 679 4701. e-mail CaWu!nso1.uchc.edu attempts to detect the release of infectious virus were not successful, indicating infection is semipermissive in nature. Upon continued passage of infected HUVEC monolayers, HHV-6 antigen-positive cells persisted up to 27 days post-infection. Furthermore, the virus could be recovered from HUVEC monolayers that contained fewer than 1 % antigen-positive cells by co-cultivation with peripheral blood mononuclear cells. Together, these findings suggest that endothelial cells may serve as a reservoir for harbouring HHV-6. lymph system and liver (Corbellino et al., 1993 ; .
The pathogenesis of HHV-6 infection is poorly understood. While HHV-6 exhibits a predominant tropism for CD4 + Tlymphocytes, the virus has been shown to infect a number of other components of blood including monocytes\macro-phages and B-lymphocytes (Ablashi et al., 1987 ; Lusso et al., 1988 ; Takahashi et al., 1989 ; Kondo et al., 1991) . Moreover, while dissemination of the virus to multiple tissues has been observed in both immunocompromised and immunocompetent patients Prezioso et al., 1992) , the mechanism of haematogenous spread is unknown. Endothelial cells lining the walls of blood vessels serve as an important barrier between components of the blood and surrounding tissues of the body. This study was designed to investigate whether HHV-6-infected T-lymphocytes could transfer infection to endothelial cells, providing a means of transmission and dissemination of the virus. Endothelial cell cultures were observed to support both HHV-6 early and late gene expression. Furthermore, the virus persists within these cells at a low frequency for several weeks, suggesting that the endothelium may serve as a reservoir for HHV-6.
(gift of Caroline Hall, University of Rochester, NY) were routinely propagated in JJhan cell cultures grown in RPMI 1640 medium supplemented with 10 % foetal bovine serum and antibiotics. Adult peripheral blood mononuclear cells (PBMC) or cord blood mononuclear cells (CBMC) were isolated from the blood of healthy individuals by separation on Ficoll-Hypaque (Pharmacia) as described by Black et al. (1989) , and used in virus rescue experiments. The level of HHV-6 infection in JJhan cells, PBMC and CBMC cultures was monitored by indirect immunofluorescent staining (IF) using antibodies against the HHV-6 DNA polymerase accessory protein as described below.
Human umbilical vein endothelial cells (HUVEC) were purchased (Clonetics) and grown according to the manufacturer's specifications in enriched endothelial cell basal medium (ECBM). Cultures from passages 5 to 10 were used in all experiments, unless otherwise noted. The homogeneity of the endothelial cells was routinely verified by staining for von Willebrand factor (Dako).
HHV-6 cell-free virus stocks were prepared by collecting the supernatants from HHV-6-infected JJhan cell cultures showing evidence of 70 % infection by indirect IF. Such cell-free inoculum routinely had a titre of 10$ TCID &! \ml. HUVEC (1i10& cells per well) were seeded on glass coverslips, maintained to 80 % confluency, and overlaid with 2i10& HHV-6-infected JJhan cells (23-50 % positive for HHV-6 antigen by indirect IF) or infected with 250 TCID &! cell-free inoculum. After 24 h, HUVEC monolayers were washed three times with ECBM and incubation continued in fresh ECBM.
HHV-6 early and late gene expression. To monitor HHV-6 infection, HUVEC were analysed for early and late viral gene expression as follows. Infected cells were fixed for 20 min at room temperature in a freshly prepared solution of 3n7 % formalin in PBS, washed three times in PBS, and permeabilized by exposure to 0n5 % Triton X-100 in PBS for 5 min. Cells were incubated at room temperature for 1 h in the presence of HHV-6 specific monoclonal antibodies (MAbs), washed in PBS, and incubated for 1 h with goat anti-mouse IgG conjugated with rhodamine (Organon Teknika). The coverslips were mounted in glycerol-veronal saline pH 8n6 (25 mM 5,5-diethylbarbituric acid, 50 mM NaCl, 50 % glycerol) in preparation for phase-contrast and fluorescence analysis using a Leitz Diaplan microscope. MAb p41 (Virotech International) is specific for the DNA polymerase accessory protein (ORF U27) from both HHV-6 variants A and B, and is a marker for early gene expression (Chang & Balachandran, 1991) . MAbs 7A2, 6A5G3 and 2D6 recognize HHV-6A and B glycoprotein 102 (ORF U48 ; glycoprotein H), HHV-6A and B glycoprotein 116 (ORF U39 ; glycoprotein B), and HHV-6A glycoprotein complex 82\105 (ORF U100), respectively (gifts of Bala Chandran, University of Kansas Medical Center, KS), and serve as markers for late gene expression (Balachandran et al., 1989 ; Chandran et al., 1992 ; Pfeiffer et al., 1993) . For quantitative purposes, each coverslip was sectioned into five areas. From each of the five sections, two fields were randomly selected and counted, with approximately 1000 cells scored for each time-point.
To verify the identity of the infected cells, HHV-6-infected HUVEC were dually stained for HHV-6 early antigen and von Willebrand factor, a marker of endothelial cell origin. Briefly, infected HUVEC monolayers were fixed and permeabilized as described above. Cells were treated with PBS with 1 % BSA and 20 mM azide for 30 min at room temperature to decrease non-specific binding, prior to incubation with HHV-6 p41. The coverslips were rinsed four times with PBS, incubated with goat antimouse IgG conjugated with peroxidase (Organon Teknika), washed with PBS and assayed for enzymatic activity in PBS containing 0n5 mg\ml 3,3h-diaminobenzidine (Sigma) and 0n012 % hydrogen peroxide. Coverslips were then blocked with 3 M urea for 30 min at room temperature, rinsed three times in PBS, and incubated with antibody against von Willebrand factor in PBS with 1 % BSA and 20 mM azide. The cells were rinsed three times in PBS and reacted with goat anti-rabbit IgG conjugated with alkaline phosphatase. After three to four washes with PBS, enzymatic activity was detected using an alkaline phosphatase substrate kit (Vector Laboratories) according to the manufacturer's specifications. The HHV-6 polymerase accessory protein is localized in the nucleus, while the staining pattern for von Willebrand factor is cytoplasmic in nature.
Analysis of viral DNA replication. HUVEC were seeded in T-25 flasks, maintained to 80 % confluency, and inoculated with cell-free virus stocks at 10$ TCID &! per 10' HUVEC. After 2 h, incubation was continued at 37 mC in fresh ECBM or ECBM plus 400 µg\ml phosphonoacetic acid (PAA). After 4 days, the monolayers were washed twice with PBS, treated with trypsin, and collected by centrifugation. The cell pellets were resuspended in 0n5 ml PBS. In a duplicate culture, the level of HHV-6A infection was determined by indirect IF. Then 6i10$ infected HUVEC in a series of threefold dilutions, along with 6i10$ HHV-6A-infected JJhan cells in a series of threefold dilutions, were spotted onto a GeneScreen Plus membrane using a Minifold I filtration apparatus (Schleicher & Schuell) . Uninfected HUVEC and JJhan cultures, at the appropriate cell concentrations, were included as negative controls. The membrane was treated twice with 1n5 M NaCl plus 0n5 M NaOH, twice with 1 M Tris-HCl pH 7n5 plus 1n5 M NaCl, and probed with a $#P-labelled HHV-6 fragment encoding the polymerase accessory protein.
After autoradiographic analysis, the data were collected by a laser scanner and the mean optical density for each dot dilution was determined using IPLab Gel Software (Signal Analytics).
Production of infectious virions. HUVEC were grown to 80 % confluency on a six-well plate and inoculated with a cell-free HHV-6 stock at 10$ TCID &! . On days 6, 8, 10 and 12 after infection, HUVEC culture supernatants were harvested and clarified by centrifugation, and 250 µl used to inoculate 4i10& CBMC grown in RPMI 1640 supplemented with 10 % foetal bovine serum, 10 ng\ml hydrocortisone and 32 units\ml interleukin-2. CBMC cultures were incubated at 37 mC for 10 days. Cells were centrifuged onto glass coverslips using a Shandon cytospin device and analysed for HHV-6 early gene expression by indirect IF using HHV-6 MAb p41 as described above.
Propagation of HHV-6 in HUVEC. HUVEC were examined for their ability to maintain HHV-6 infection. Specifically, T-25 flasks of HUVEC were infected with HHV-6A cell-free inoculum, as described above. Upon reaching confluency, the HUVEC monolayers were washed with PBS, treated with trypsin, and collected by centrifugation. One-third of the resulting cell pellet was maintained in culture, one-third was seeded onto a coverslip and fixed within 6 h for indirect IF, and the remaining one-third was discarded. This pattern of propagation was continued approximately every 5 days for 5-6 weeks and resulted in HUVEC monolayers up to passage 14. When no HHV-6 gene expression was detected (as measured by indirect IF with p41 antibody) for two passages, HUVEC monolayers were maintained untreated ; treated with 3 mM sodium butyrate ; or treated with 12-O-tetradecanoylphorbol 13-acetate (TPA) at 14n3 ng\ml. After 24 h, the medium was removed and HUVEC monolayers were co-cultured with 1i10' CBMC for 6 h. The CBMC were removed and maintained in a separate T-25 flask, while the HUVEC were incubated in fresh ECBM. Both HUVEC and CBMC were assayed for HHV-6 early gene expression by indirect IF 4 and 10 days, respectively, after co-cultivation.
Pretreatment of HUVEC with cytokines.
To determine the effect of various mediators and cytokines on HHV-6 infection of endothelial cells, HUVEC were seeded onto coverslips and pretreated 24 h prior to BCEI infection with lipopolysaccharide (Sigma), recombinant tumour necrosis factor-α (TNF-α) (Genentech), recombinant interleukin 1α (IL-1α) (Genzyme Diagnostics), recombinant interferon α2b (IFN-α) (Schering), or recombinant interferon-γ (IFN-γ) (Genzyme Diagnostics) at the indicated concentrations. After co-cultivation for 24 h with 2i10& HHV-6A-infected JJhan cells, the HUVEC monolayers were washed three times and incubated with medium in the absence of cytokines. Three days after infection, indirect IF staining for HHV-6 early gene expression was performed with MAb p41, as described above.
Results

HHV-6 early and late gene expression in endothelial cells
To determine the susceptibility of endothelial cells to HHV-6, monolayers of HUVEC were overlaid with HHV-6A isolate U1102-infected JJhan cells. During the course of infection enlarged, multi-nucleated cells were observed by phase microscopy in infected HUVEC cultures ( Fig. 1 C) . These foci appeared within 24 h, and were not present in HUVEC exposed to uninfected JJhan cells ( Fig. 1 A) .
Early and late viral gene expression was detected in HHV-6A-infected HUVEC monolayers by indirect IF 3 days after infection. Using a MAb specific for the DNA polymerase accessory protein (antibody p41), early viral antigen was detected in infected HUVEC nuclei. The staining pattern observed was both diffuse throughout the nucleus and a distinct punctate design (Fig. 1 D) . Late gene expression was monitored with a MAb against the glycoprotein complex 82-105 (antibody 2D6). In this case, staining was cytoplasmic in nature (Fig. 1 F) . Multi-nucleated syncytia, as well as individual cells within the HUVEC monolayer, stained positive for both early and late HHV-6 proteins. HUVEC monolayers co-cultured with uninfected JJhan cells exhibited no nuclear (Fig. 1 B) or cytoplasmic (data not shown) fluorescence with either antibody.
Susceptibility of endothelial cells to viral infection was not limited to an HHV-6A variant. Co-cultivation of HUVEC monolayers with HHV-6B isolate R255-infected JJhan cells resulted in the production of enlarged, multi-nucleated foci as described above. Both early and late gene expression was detected using MAbs p41 and 7A2 (glycoprotein 102), respectively ( Fig. 1 H, J) . In contrast to the pattern of early antibody staining observed with HHV-6A, HHV-6B-infected-HUVEC exhibited only a punctate pattern (Fig. 1 , compare D and H).
Phenotypic identification of HHV-6-infected cells
In the experiments described above, HHV-6-infected JJhan cells were used as the source of infectious material. The majority ( 90 %) of both infected and uninfected JJhan cells were removed from the endothelial cell culture by extensive washing, and the remaining JJhan cells were morphologically distinct from the HUVEC monolayer. However, to confirm the phenotypic identity of HHV-6 antigen-positive cells, infected HUVEC were dually stained with HHV-6 p41 antibody and a MAb specific for von Willebrand factor (factor VIII), a glycoprotein synthesized by endothelial cells (Wagner, 1990) . Mock-infected (A) and HHV-6A-infected (B, C) HUVEC monolayers were analysed by immunohistochemical staining 3 days p.i. using polyclonal antibody specific for von Willebrand factor (purple, cytoplasmic stain) and MAb to the HHV-6 polymerase accessory protein (brown, nuclear stain). Magnification : A, i400 ; B and C, i1000.
in purple (Fig. 2 B, C) . Several of the endothelial cells also exhibited a brown nuclear stain, indicative of HHV-6 early antigen. It is interesting to note in Fig. 2 (C) that only two out of four HUVEC nuclei present in the syncytium are positive for HHV-6 early antigen. As a control, endothelial cells were cocultured with uninfected JJhan cells and dually stained as described above. Such cultures were uniformly positive for von Willebrand factor, exhibiting a strong cytoplasmic staining pattern (Fig. 2 A) , but lacked nuclear staining, denoting an absence of HHV-6 early antigen.
Time-course of HHV-6 infection
HHV-6A early and late gene expression in HUVEC was monitored over time using the indirect IF assay described in Methods. Four independent experiments were performed and the data from two representative experiments are shown in Fig. 3 . HUVEC, co-incubated with HHV-6A-infected JJhan cells, exhibited early viral gene expression 24 h after infection (Fig. 3 A) . The number of HHV-6 p41 positive cells increased with time, peaking between days 3 and 4 post infection (p.i.), with a maximum of 37n6 % of the monolayer staining positive for the virus. The synthesis of HHV-6 late proteins was first noted on day 2 after infection, and the frequency of HUVEC expressing HHV-6 late antigens increased only slightly with time from 2n0 % on day 2 to 6n4 % on day 4. This ratio of cells synthesizing early versus late gene products, approximately 5 to 1, was consistently observed in four separate experiments. No IF staining was observed in HUVEC co-incubated with uninfected JJhan cells using antibodies specific for either the HHV-6 early or late gene products.
HHV-6A early and late gene expression was also examined in HUVEC using cell-free virus inoculum (Fig. 3 B) . The number of cells expressing HHV-6 early antigen increased gradually from day 1 to day 5 after infection, reaching a maximum level of 29n2 %. Expression of HHV-6 late gene products was first detected on day 2 and reached a plateau of 7n2 % on day 4. These results depict a similar ratio of early to late gene expression as compared with experiments using HHV-6-infected JJhan cells as the inoculum.
The total number of HUVEC present in infected cultures was monitored over time and compared with the number of endothelial cells present in mock-infected cultures at the same time point. The results from the experiments in Fig. 3 (A, B) were calculated as a percentage of control and summarized in Fig. 3 (C) . When using either HHV-6-infected JJhan cells or cellfree virus as the inoculum, only 40 % of the HUVEC monolayer remained intact at 5 days p.i. This pronounced decrease in the number of HUVEC present in culture suggests that HHV-6 infection leads to destruction of the endothelium.
Replication of HHV-6 DNA
In the time-course experiments described above, only a portion of HUVEC expressing HHV-6 early antigen progressed in the virus life-cycle to express late viral proteins. In permissive cells, the synthesis of viral proteins follows a cascade pattern with efficient synthesis of late gene products being dependent upon viral DNA replication. To determine whether this partial block in late gene expression occurred before or after HHV-6 DNA replication, infected HUVEC cultures were studied for their ability to support viral DNA synthesis. Serial dilutions of total DNA extracted from HHV-6-infected HUVEC, maintained in the presence or absence of PAA, or HHV-6-infected JJhan cells were examined by dotblot analysis using a virus-specific probe. As illustrated in Fig.  4 , at 4 days p.i. the amount of viral DNA present in HHV-6-infected HUVEC was comparable to that isolated from infected JJhan cells. Detection of viral DNA could not be attributed to input virus since treatment with PAA, a potent inhibitor of viral DNA replication, reduced the signal to a level observed in uninfected cells. In addition, a cell-free virus stock was used during infection of the endothelial cells to exclude the possibility of signal arising from contaminating HHV-6-infected JJhan cells. Thus, while this approach is only semiquantitative in nature, the results are consistent with the idea that viral DNA replication occurs in HUVEC and that the block in the HHV-6 pathway occurs after DNA synthesis in the majority of endothelial cells.
Production of infectious virus
As outlined in the studies above, a limited number of endothelial cells can support HHV-6 late gene expression. To determine whether this population of cells can also generate and release infectious virus, culture supernatants were incubated with PBMC and assayed by indirect IF for the presence of HHV-6 antigens. Two separate experiments were performed, analysing culture fluids collected on days 6, 8, 10 and 12 p.i. The results from both experiments, at all time-points examined, were negative. As a positive control, PBMC were inoculated with cell-free virus stocks under identical conditions and assayed for early viral gene expression. These cultures were positive, proving that the PBMC cultures were susceptible to HHV-6 infection. The expression of early viral proteins in HHV-6-infected HUVEC cultures was also monitored in these experiments and ranged from 8n5-20 %. This level of infection in permissive cells is sufficient for detecting the release of virus into the culture medium. Together, these results suggest that infectious virus was not released into the culture medium at detectable levels.
Persistent infection of HUVEC
To determine if HHV-6 can be maintained in HUVEC over an extended period of time, infected monolayers were continuously passaged and monitored for HHV-6 antigen expression by indirect IF. In these studies, the initial level of infection was low in order to keep destruction of the monolayer to a minimum. The results from two independent experiments are shown in Table 1 , with infection of HUVEC performed in Table 1 . Chronic infection of HUVEC monolayers by HHV-6 HUVEC monolayers were infected with HHV-6A cell-free virus in triplicate (i-iii) and passaged, monitoring early viral gene expression by indirect IF. The results from two independent experiments are shown. The data represent the meanpSD of ten fields scored.
Experiment 1
Experiment 2 HHV-6 antigen-positive cells (%)
HHV-6 antigen-positive cells (%) Passage no.
Passage no. (38) * The value 0n1 % is given for no HHV-6 p41 antigen-positive cells observed in ten fields scored ; however, on scanning the entire coverslip HHV-6-positive HUVEC were found. , Not done. triplicate under identical conditions. After the first passage the number of antigen-positive cells declined rapidly to less than 1 %. This reduction is most notable in experiment 2 where the initial frequency of cells synthesizing early viral proteins was between 7 and 13 %. Surprisingly, continued passage of HUVEC demonstrated the presence of a small population of endothelial cells expressing HHV-6 p41 antigen. The number of antigen-positive cells decreased slowly with passage, but positive cells were detected up to day 27 p.i. These results suggest that HHV-6 can establish a chronic infection in endothelial cells that can persist for up to 4 weeks.
When no antigen-positive cells were observed for two passages (passages 8 and 7 for experiments 1 and 2, respectively), HUVEC monolayers were overlaid with PBMC (experiment 1) or CBMC (experiment 2) for 24 h. PBMC\ CBMC were removed from the monolayers and incubation continued for 10 days. This resulted in no recovery of virus in PBMC\CBMC cultures as determined by the lack of cytopathic effect and the absence of early viral gene expression. Treatment of the HUVEC monolayer with TPA or sodium butyrate prior to co-cultivation had no effect on the outcome. Furthermore, HUVEC monolayers showed no evidence of HHV-6 gene expression after treatment. In contrast, HHV-6 was successfully isolated from monolayers that contained a small number of virus-infected cells. Table 2 shows the results from two independent experiments where the frequency of HHV-6 antigen-positive endothelial cells dropped to less than 1 % after the first passage. At this time HUVEC were co-incubated with PBMC, and 10 days after co-cultivation positive PBMC were detected by indirect IF assay. Attempts to rescue virus from BCFC Table 2 . Recovery of HHV-6 from infected endothelial cells HUVEC monolayers were mock infected or infected with HHV-6A cell-free virus and passaged once, monitoring early viral gene expression. The number of HHV-6 antigen-positive HUVEC present after the first passage is indicated. HUVEC monolayers were overlaid with PMBC. The number of HHV-6-positive PMBC was determined 10 days after co-cultivation by IF. The results from two independent experiments are shown. The data represent the meanpSD of ten fields scored. Table 3 . Effect of various cytokines on HHV-6 early gene expression in HUVEC monolayers
HHV-6 antigen-
Four independent experiments were performed. The results from a representative experiment are shown. The data are the mean number of cellspSD in ten fields. * Significant at P 0n01 ; ** significant at P 0n05. Statistical analysis was performed using a Student's t-test.
Pretreatment of HUVEC
HHV-6 antigen-positive cells (%)
0* IL-1α (125 units\ml) 8n0p8n2 IFN-α (10 000 units\ml) 8n3p11n0 IFN-α (50 000 units\ml) 7n6p3n9** IFN-γ (2 000 units\ml) 8n1p5n0 IFN-γ (10 000 units\ml) 6n8p5n5** mock-infected HUVEC, passaged once prior to co-cultivation with PBMC, were negative. The ability to recover virus from infected HUVEC indicates that endothelial cells can serve as a reservoir for HHV-6.
IFN-α, IFN-γ and TNF-α inhibit HHV-6 early gene expression in HUVEC
Several studies have shown that infection of PBMC with HHV-6 can induce alterations in the production of cytokines (Kikuta et al., 1990 ; Flamand et al., 1991 ; Gosselin et al., 1992) . To determine the effects of various cytokines and mediators on the susceptibility of endothelial cells to HHV-6 infection, early gene expression was monitored by indirect IF. The results from a representative study are shown in Table 3 . When HUVEC were pretreated with either 0n5 or 2n5 µg\ml TNF-α, early gene expression was abolished. Yet even in the absence of early gene expression, multi-nucleated syncytia (a characteristic cytopathic effect of HHV-6 infection) were still observed. However, exposure of HUVEC to physiological concentrations of TNF-α resulted in no reduction of HHV-6 early proteins.
Discussion
The purpose of these studies was to determine if HHV-6 could be transmitted from T-lymphocytes to the endothelium by cell-to-cell contact, establishing a model system for examining the dissemination of the virus from components of the blood through the vascular endothelium lining blood vessels to other tissues throughout the body. Many of the experiments in this report have employed HHV-6-infected lymphocytes as the source of infectious material, instead of cell-free virus, to more closely mimic the interactive cellular events occurring in vivo. Using indirect IF assays and dual immunohistochemical techniques, the results presented here demonstrate that endothelial cells are susceptible to HHV-6 infection. Both HHV-6 early and late viral gene products were detected in HUVEC monolayers exposed to isolate U1102 or R255, representing HHV-6 strains A and B, respectively (Fig.  1) . Such an interactive exchange between circulating blood components and the endothelium has also been observed for human cytomegalovirus (HCMV), another betaherpesvirus (Waldman et al., 1995) . In this case transfer of virus was from endothelial cells, a natural host for HCMV in vivo, to monocytes.
Although HHV-6 is capable of infecting HUVEC, only a small percentage of endothelial cells expressing early antigens progressed in the viral cascade to produce late proteins (Fig.  3 A, B ) and attempts to detect the release of infectious progeny in the culture supernatant were unsuccessful. In permissive cell lines, the ratio of virus particle to infectivity is low, approximately 1000 to 1 (Skiraki et al., 1991) . However, adjusting for this fact and the lower frequency of infection in HUVEC monolayers, the sensitivity of the assay is still sufficient to achieve detection of released virus. These findings suggest that HHV-6 infection of HUVEC is only semi-permissive in nature. HHV-6 infection of other non-immune cells, including fibroblasts, epithelial cells and astrocytes, also appears to be somewhat restricted, resulting in virus titres that are 100-to 1000-fold lower than those produced in CD4 + T-lymphocytes, the natural host for HHV-6 (Luka et al., 1990 ; Simmons et al., 1992 ; He et al., 1996) . The biological basis for efficient replication of HHV-6 only in lymphoid cells is uncertain. It is interesting to note that while HCMV can productively infect human brain capillary endothelial cells (Lathey et al., 1990 ; Poland et al., 1990) , the ability of the virus to replicate efficiently in HUVEC is limited (Smiley et al., 1988 ; Wu et al., 1994) . These studies emphasize the biochemical and phenotypic heterogeneity that exists between microvascular and large-vessel endothelial cells (Zetter, 1988) .
The number of infected HUVEC identified in the timecourse experiments (Fig. 3 A, B ) may in fact be an underestimation due to loss of cells from the monolayer during the course of HHV-6 infection (Fig. 3 C) . Whether these unattached cells represent HHV-6-infected endothelial cells, uninfected HUVEC or a mixed population remains to be elucidated. Nonspecific staining of non-viable cells does not allow this question to be addressed with indirect IF techniques. However, two plausible explanations for the loss of HUVEC come to mind. Firstly, HHV-6 infection could result in the release of a soluble factor that is toxic to HUVEC and thus lead to cell death. HHV-6 has been documented to induce the secretion of various cytokines (Kikuta et al., 1990 ; Flamand et al., 1991 ; Gosselin et al., 1992) . However, in this study incubation of HUVEC cultures with TNF-α, IL-1, INF-α or INF-γ did not lead to appreciable cell loss (unpublished results). Therefore, we favour a second explanation which involves HHV-6 as a direct cause of cell lysis and destruction. The relationship between HHV-6 and its host has been well documented for Tlymphocytes. Here, infection by HHV-6 causes the development of large refractile cells that die within 10-12 days (Salahuddin et al., 1986) . In a second study, a comparison of the number of cells present in HHV-6-infected versus mockinfected CBMC 5 days after infection revealed a 20 % decline in infected cultures, an effect that was consistent in numerous experiments (Black et al., 1991) . In addition, HHV-6 can suppress cell proliferation and IL-2 production (Horvat et al., 1993 ; Flamand et al., 1995) , as well as shut off host-cell DNA replication (DiLuca et al., 1990) . Further studies must be undertaken to determine if HHV-6 has a similar effect on its endothelial cell host.
The present data suggest that HHV-6 does not replicate productively in HUVEC. However, the virus was maintained in continually passaged HUVEC for almost a month (Table 1) and HHV-6 was recovered from these monolayers by cocultivation with permissive PBMC. These findings indicate that endothelial cells can serve as a repository for chronic HHV-6 infection. Our inability to rescue the virus from HUVEC monolayers that were HHV-6 antigen negative for two passages is consistent with the idea that while the virus can persist in these cells, the endothelium is not a site for viral latency. However, it is possible that our attempts to recover HHV-6 have met with failure due to culture conditions. Kondo et al. (1991) have reported that HHV-6 can be reactivated from human monocytes\macrophages in vitro only after pretreatment with TPA for 5 days. Our HUVEC cultures were pretreated with TPA, but only for 24 h due to the sensitive nature of the cells. Katsafanas et al. (1996) have described the reactivation of HHV-6 from latently infected PBMC in vitro, a process that is dependent on active infection with human herpesvirus-7 (HHV-7). They concluded that HHV-7 provides a trans-acting function necessary for the rescue of HHV-6. Studies are now under way in our laboratory to test whether such factors will influence HHV-6 recovery from HUVEC.
Defence mechanisms designed to protect the host against invading viruses activate a number of cell-mediated immune strategies, including the release of cytokines. These soluble regulatory elements, secreted primarily by monocytes\ macrophages, serve an important function in virus clearance from the infected site (Ramsay et al., 1993) . HHV-6 infection of PBMC elicits the synthesis of TNF-α, IL-1 and IFN-α (Kikuta et al., 1990 ; Flamand et al., 1991 ; Gosselin et al., 1992) , mediators that exert a profound influence on the structure and function of the endothelium (Pober, 1992 ; Mantovani et al., 1992 ). Using our model system, we examined the effect of these cytokines on the susceptibility of endothelial cells to HHV-6 infection in vitro, to help define their potential role in preventing the spread of virus in vivo. Exposure of endothelial cells to TNF-α prior to viral infection induced the most pronounced responsecomplete inhibition of early antigen expression (Table 3) . However, such an effect occurred only at concentrations 1000-fold greater than physiological levels. The antiviral effects of TNF-α are well established for alphaherpesviruses. TNF-α selectively kills herpes simplex virus type 1-and type 2-infected cells by accelerating cell lysis, leaving uninfected cells intact (Wong & Goeddel, 1986 , Koff & Fann, 1986 Ito & O'Malley, 1987) . This antiviral effect of TNF-α is synergistically enhanced by the presence of IFN-γ, inhibiting replication of the virus more efficiently than can be observed with either molecule alone (Wong & Goeddel, 1986 ; Feduchi et al., 1989) . The combined antiviral activity of TNF-α and IFN-γ has also been reported for betaherpesviruses. While high concentrations of TNF-α or IFN-γ alone were necessary to invoke any antiviral activity, when tested in combination the effective concentrations of these two mediators were reduced to physiological levels (Lucin et al., 1994) . Whether combined therapy would reduce the levels of TNF-α necessary to inhibit HHV-6 synthesis is currently being tested.
With regard to pathogenicity and spread of the virus, the present studies demonstrate two important findings : (a) HUVEC can serve as a reservoir for HHV-6 in vitro, and (b) HHV-6 infection of HUVEC leads to cell loss. Thus the susceptibility of the endothelium to HHV-6 infection may help explain the widespread nature of the virus in immunocompromised patients.
